Vaneltix Pharma, Inc.

Vaneltix Pharma, Inc. logo
🇺🇸United States
Ownership
Holding, Private
Established
1997-01-01
Employees
11
Market Cap
-
Website
https://vaneltix.com

Safety, Efficacy, and Frequency of Administration of VNX001 in the Treatment of Interstitial Cystitis / Bladder Pain Syndrome (IC/BPS)

Phase 2
Not yet recruiting
Conditions
Interventions
First Posted Date
2024-05-01
Last Posted Date
2024-11-25
Lead Sponsor
Vaneltix Pharma, Inc.
Target Recruit Count
50
Registration Number
NCT06394830

Safety and Efficacy Study of VNX001 Compared to Its Individual Components (Lidocaine and Heparin) or Placebo in Subjects With IC/BPS

First Posted Date
2023-02-21
Last Posted Date
2024-11-20
Lead Sponsor
Vaneltix Pharma, Inc.
Target Recruit Count
120
Registration Number
NCT05737121
Locations
🇺🇸

IC Study LLC, Escondido, California, United States

🇺🇸

University of California Los Angeles Center for Women's Pelvic Health, Los Angeles, California, United States

🇺🇸

The Continence Center Medical Group, Inc dba Southern California Continence Center, Newport Beach, California, United States

and more 8 locations
© Copyright 2024. All Rights Reserved by MedPath